Improving antiviral medication for COVID-19 to give more patients access to treatment

Researchers from the University of Alberta (U of A) are working to improve the only oral antiviral approved for COVID-19 infections in the hopes of expanding its use in populations that need it most.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart